GBM tumor development and growth reduction was suggested due to garcinol abrogating STAT3/5A signaling and upregulating hsa-miR-181d, with concomitant suppression of the Ki-67 proliferation index and enhancement of Bax/Bcl-xL apoptotic ratio [90]. This evidence concerns the gene BCL2L1 and glioblastoma.